Page last updated: 2024-09-03

l 670596 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

l 670596 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Compound Research Comparison

Studies
(l 670596)
Trials
(l 670596)
Recent Studies (post-2010)
(l 670596)
Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
21009,156187552

Protein Interaction Comparison

ProteinTaxonomyl 670596 (IC50)1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)
Platelet-activating factor receptorHomo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Catto-Smith, AG; Gall, DG; MacNaughton, WK1

Other Studies

1 other study(ies) available for l 670596 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2

    Topics: Anaphylaxis; Animals; Azepines; Biological Transport; Carbazoles; Dinoprostone; Electrolytes; Female; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Jejunum; Leukotriene Antagonists; Leukotrienes; Phospholipids; Platelet Activating Factor; Propionates; Quinolines; Rats; Thromboxanes; Triazoles

1992